;
RNS Number : 2499I
Hill & Smith Holdings PLC
13 April 2022
 

13 April 2022

 

Hill & Smith Holdings PLC

 

CORRECTION: Director/PDMR Shareholding

 

The following amendment has been made to the "Director/PDMR shareholding" announcement released on 12 April 2022 at 08.40 under RNS No 0997I

 

In section 4 (d) of the PDMR form this should read Price '£14.4069' not 'Price £1440.69' as previously stated.

 

As a result of this purchase Mr Farrokh Batliwala has a beneficial interest in 2,000 shares in Hill & Smith Holdings PLC at a value of £28,813.80.

 

All other details remain unchanged.

 

Director/PDMR Shareholding

 

Hill & Smith Holdings PLC ('Hill & Smith' or 'the Company') announces that it has been notified that Farrokh Batliwala, Non-executive Director of Hill & Smith, has purchased 2,000 ordinary shares in the Company ('Ordinary Shares').

 

As a result of this transaction, Mr Batliwala now has a beneficial interest in 2,000 Ordinary Shares.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Farrokh Batliwala

2.

Reason for the notification

(a)

Position/status

Non-executive Director

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith Holdings PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Open Market Purchase

(d)

Price(s) and volume(s)

Price(s)

Volume

£14.4069

2,000

 

(e)

Aggregated information

N/A single transaction

(f)

Date of the transaction

8 April 2022

(g)

Place of the transaction

LON

 

Enquiries:

 

Alex Henderson

Company Secretary

0121 704 7430

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUUGCUPPUMW